However, the DGKG expression profile was contradictory to our aforementioned results; furthermore, we found that the expression levels of MAP3K7IP2 and NFKBIE in the AD group were not significantly different from those in the WT group (Figures 7A–E). This evidence concerns the gene NFKBIE and Alzheimer disease.